Quintet Private Bank (Europe)’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-17,700
Closed -$928K – 197
2026
Q2
$928K Hold
17,700
– – 0.06% 67
2026
Q1
$977K Hold
17,700
– – 0.07% 62
2025
Q4
$868K Hold
17,700
– – 0.05% 74
2025
Q3
$764K Hold
17,700
– – 0.04% 80
2025
Q2
$680K Hold
17,700
– – 0.04% 81
2025
Q1
$686K Hold
17,700
– – 0.04% 85
2024
Q4
$599K Hold
17,700
– – 0.03% 94
2024
Q3
$724K Buy
17,700
+2,260
+15% +$92.5K 0.04% 87
2024
Q2
$682K Sell
15,440
-7,448
-33% -$313K 0.04% 89
2024
Q1
$1.12M Buy
+22,888
New +$944K 0.05% 86

Other funds holding GSK

Quintet Private Bank (Europe)'s GSK Position: Q3 2026 in Review

Quintet Private Bank (Europe) sold out of GSK (GSK) in Q3 2026, closing a stake of 17,700 shares — an estimated $928K sold.

Quintet Private Bank (Europe) first reported a position in GSK in Q1 2024 and held it in 10 quarters. The position peaked at $1.12M in Q1 2024. 35 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Quintet Private Bank (Europe) reported no remaining GSK position as of Q3 2026 after selling out during the quarter.
  • Quintet Private Bank (Europe) sold 17,700 GSK shares in Q3 2026, an estimated $928K.
  • Quintet Private Bank (Europe) first reported a position in GSK in Q1 2024 and held it in 10 quarters.
  • Quintet Private Bank (Europe)'s GSK position peaked at $1.12M in Q1 2024.
  • 35 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Quintet Private Bank (Europe)'s 13F filing for Q3 2026, filed 8 Oct 2026.